ascopubs.org

HLA Class II Expression by Hodgkin Reed-Sternberg Cells Is an Independent Prognostic Factor in Classical Hodgkin's Lymphoma

Doctors’ and Patients’ Preferences for Participation and Treatment in Curative Prostate Cancer Radiotherapy Immunohistochemistry results for HLA class II were evaluated in 292 primary cHL patients in ...
Fred Hutch

HLA haplotype allelic variations can influence leukemia recurrence after blood stem cell transplantation

“Since the discovery of transplantation as a life-saving therapy for blood malignancies by Dr. E Donnall Thomas, there have been major advances that have significantly lowered the side effects and ...
Seeking Alpha

Elicio Therapeutics Reports Robust T cell Responses Across Diverse HLA backgrounds in Ongoing Phase 2 AMPLIFY-7P Trial

ELI-002 7P demonstrated robust mKRAS-specific T cell responses across a broad range of HLA types, highlighting its potential for use among a diverse patient population Patients treated with ELI-002 7P ...
EurekAlert!

Rare peptide anchors of HLA class I alleles contribute to the COVID-19 disease severity and T cell memory

This study analyzed and proposed the potential association of specific HLA alleles with SARS-CoV-2 infection. Several studies have investigated the association of different HLA alleles with COVID-19.
EurekAlert!

HLA class II alleles associated with ANCA-associated vasculitis in Japanese patients

Vasculitis is a group of conditions that results in inflammation of the blood vessels. Symptoms include rash, shortness of breath, vision loss, and kidney failure depending on the location of the ...
Morningstar

RheumaGen, Inc. Launches with $15 Million Series A Financing to Advance a New Class of HLA Gene-Editing Therapies for Major Autoimmune Diseases

AURORA, Colo., Jan. 9, 2025 /PRNewswire/ -- RheumaGen, Inc., a cell and gene therapy company engineering a new class of therapeutics for major autoimmune diseases, announced today the close of a $15 ...